Quorum Review IRB Awarded Full Reaccreditation by AAHRPP
Quorum Review IRB has been awarded full reaccreditation for another three years by the Association for the Accreditation of Human Research Protection Programs (AAHRPP).
AAHRPP accredits organizations that can demonstrate they provide participant safeguards that surpass the threshold of state and federal requirements. The accreditation program utilizes a voluntary, peer-driven review and educational model.
Through the accreditation process, organizations must demonstrate that they have built extensive safeguards into every level of their research operation and that they adhere to the highest standards for research. AAHRPP’s standards exceed federal regulations by requiring organizations to address conflicts of interest, to provide community outreach and education, and to apply the same stringent protections to all research involving human participants.
Quorum Review was initially awarded full accreditation status from AAHRPP in April of 2006. Accredited organizations are required to renew their accreditation with AAHRPP every three years to demonstrate compliance with current AAHRPP criteria.
Since the last review by AAHRPP in 2006, Quorum has made several changes to its service offerings, including reviewing studies in Canada. Because of these changes, AAHRPP applied the Canadian Tri-Council Policy Statement guidelines in addition to U.S. guidelines in reviewing Quorum’s processes. Quorum is now one of only a few AAHRPP-accredited IRBs that is specifically accredited to review studies in Canada as well as the United States.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Empower Sponsor Success with Insights from Sites
October 3rd 2024Are you tired of clinical trial technology that slows down processes? Are your sites looking for more intuitive solutions? At YPrime, we’ve taken a deep dive into site experiences and perspectives, sharing ways to bridge the gap between sponsors, sites, and patients, to foster a more efficient clinical trial process.
